In T1DM and T2DM mice, the increased levels of glial fibrillary acidic protein (GFAP) are considered as the activation of SGCs, which have been shown to be associated with the induction of neuropathic pain (Hanani et al., 2014; Liu et al., 2016). This evidence concerns the gene GFAP and type 1 diabetes mellitus.